News

US Capital Global Strengthens European Operations with New Leaders

US Capital Global Strengthens European Operations with New Leaders

Exciting Developments at US Capital Global

US Capital Global is making waves by expanding its London office, showcasing its commitment to growth and excellence in the financial services sector. Recently, the firm announced the addition of three highly experienced bankers to its team: Michael Silberberg, Mark Olson, and James Bowles. These new appointments are expected to significantly enhance the firm's capabilities in investment banking, private equity, and other innovative financial solutions.

Meet the New Additions

Michael Silberberg - Managing Director

Michael Silberberg steps in as Managing Director, bringing over two decades of experience in strategic advisory roles and capital raising across various high-growth sectors. His remarkable career includes leadership positions at tech giants and successful ventures in artificial intelligence and digital assets. He is recognized for his expertise in innovation and capital markets.

Mark Olson - Managing Director

Joining as Managing Director, Mark Olson will focus on capital formation specifically tailored for mid-market companies. With a wealth of knowledge gained from over 25 years in private capital markets, he is adept at structuring financial solutions and ensuring operational excellence for both family offices and institutional investors.

James Bowles - Vice President

James Bowles takes the reins as Vice President, bringing a rich background in asset management and structured finance. With experience spanning over 25 years, James excels at forming strategies for private equity and real estate investments, particularly targeting high-net-worth individuals and institutional clients.

US Capital Global's Commitment to Excellence

US Capital Global operates as a full-service financial group with a broad range of services including corporate finance, asset management, and capital formation. With strategic offices located in key global cities, the firm continues to establish a strong presence in the financial sector, meeting the diverse needs of its clientele.

Leadership Remarks on the New Appointments

The firm’s Founder and Chairman, Jeffrey Sweeney, expressed his enthusiasm: "Welcoming these exceptional professionals marks a pivotal moment in our European strategy. Their industry insight and proven abilities will ensure we provide our clients with even more customized financial solutions, catering to a vastly evolving marketplace."

About US Capital Global

Founded in 1998, US Capital Global specializes in advanced financial solutions for middle-market enterprises and investors. The firm offers an extensive look at investment banking and wealth management services, ensuring every aspect of M&A and capital raising is expertly handled. Prominent divisions under US Capital Global include US Capital Global Investment Management LLC and US Capital Global Securities LLC, registered with both the SEC and FINRA.

Contact Information

If you’re interested in learning more about some unique investment opportunities, get in touch with Jeffrey Sweeney, Founder and Chairman of US Capital Global, by sending an email to info@uscapital.com.

Frequently Asked Questions

What is the primary business focus of US Capital Global?

US Capital Global focuses primarily on delivering expansion capital, corporate finance, and asset management services for middle-market companies globally.

Who are the new managing directors at US Capital Global?

The new managing directors are Michael Silberberg and Mark Olson, who both bring extensive experience and strategic insights to the firm.

What can clients expect from US Capital Global's expanded operations?

Clients can anticipate enhanced financial solutions and innovative investment strategies tailored to meet diverse market needs following the expansion.

How long has US Capital Global been in operation?

US Capital Global was founded in 1998, making it a well-established player in the financial services industry.

How can I contact US Capital Global for investment inquiries?

You can reach out via email to media@uscapglobal.com for any investment-related questions or inquiries.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 223

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 154

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 122

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
ManuTech Center Set to Revolutionize Manufacturing Hub

Updated Category News Views 207

Jackson's Next Manufacturing Frontier Well, the folks down in Jackson, Michigan, are prepping to cut the red ribbon on something that's got me leaning forward in my seat. The Advanced Manufacturing Training Center (AMTC) is pulling out all the stops with their new ManuTech Prototyping Center. Yup, this center is about to become the playground for startups, manufacturers,...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 22

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 148

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 225

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 155

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 150

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 233

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
les" class="btn" href="https://investorshangout.com/blog/news?page=2">More News Articles